Autonomix Medical Common Stock Net Income
| AMIX Stock | 0.53 0.01 1.13% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Autonomix Medical's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Net Loss | -10.3 M | -10.8 M | |
| Net Loss | -10.3 M | -10.8 M | |
| Net Loss | (7.43) | (7.80) |
Autonomix | Net Income | Build AI portfolio with Autonomix Stock |
Autonomix Medical Common Company Net Income Analysis
Autonomix Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Autonomix Medical Net Income | (11.41 M) |
Most of Autonomix Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Autonomix Medical Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Autonomix Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Autonomix Medical is extremely important. It helps to project a fair market value of Autonomix Stock properly, considering its historical fundamentals such as Net Income. Since Autonomix Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Autonomix Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Autonomix Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Autonomix Operating Income
Operating Income |
|
Based on the recorded statements, Autonomix Medical Common reported net income of (11.41 Million). This is 103.34% lower than that of the Health Care Equipment & Supplies sector and 104.79% lower than that of the Health Care industry. The net income for all United States stocks is 102.0% higher than that of the company.
Autonomix Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Autonomix Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Autonomix Medical could also be used in its relative valuation, which is a method of valuing Autonomix Medical by comparing valuation metrics of similar companies.Autonomix Medical is currently under evaluation in net income category among its peers.
Autonomix Fundamentals
| Return On Equity | -3.52 | ||||
| Return On Asset | -1.59 | ||||
| Current Valuation | (6.98 M) | ||||
| Shares Outstanding | 6.91 M | ||||
| Shares Owned By Insiders | 6.71 % | ||||
| Shares Owned By Institutions | 4.77 % | ||||
| Number Of Shares Shorted | 133.86 K | ||||
| Price To Book | 0.58 X | ||||
| EBITDA | (11.05 M) | ||||
| Net Income | (11.41 M) | ||||
| Total Debt | 1.71 M | ||||
| Book Value Per Share | 1.04 X | ||||
| Cash Flow From Operations | (8.26 M) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (4.51) X | ||||
| Target Price | 6.6 | ||||
| Market Capitalization | 3.71 M | ||||
| Total Asset | 9.81 M | ||||
| Retained Earnings | (50.38 M) | ||||
| Working Capital | 7.9 M | ||||
| Net Asset | 9.81 M |
About Autonomix Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Autonomix Medical Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Autonomix Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Autonomix Medical Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.